Seth Inzaule

Seth Inzaule

  • PhD Fellow

Seth C. Inzaule is a PhD student at the University of Amsterdam and the University of Barcelona under the Erasmus Fellowship. His research has been on long-term and successful antiretroviral treatment outcomes in HIV-infected patients in sub-Saharan Africa, within the Pan-African Studies to Evaluate Resistance in Africa (PASER), with particular focus on adherence, resistance and diagnostics. His PhD supervisors are Prof. Tobias Rinke de Wit and Dr. Raph Hamers.


High prevalence of HIV drug resistance among newly diagnosed infants aged <18 months: results from a nationwide surveillance in Nigeria.
Inzaule SC, Osi SJ, Akinbiyi G, Emeka A, Khamofu H, Mpazanje R, Ilesanmi O, Ndembi N, Odafe S, Sigaloff KCE, Rinke de Wit TF, Akanmu S.
J Acquir Immune Defic Syndr. 2017 Sep 25. doi: 10.1097/QAI.0000000000001553. [Epub ahead of print]
PMID: 28961680

The evolving landscape of HIV drug resistance diagnostics for expanding testing in resource-limited settings.
Inzaule SC, Hamers RL, Paredes R, Yang C, Schuurman R, Rinke de Wit TF.
AIDS Rev. 2017 Feb 9;19(2).
PMID: 28182618

Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya.
Inzaule SC, Hamers RL, Mukui I, Were K, Owiti P, Kwaro D, Rinke de Wit TF, Zeh C.
AIDS. 2017 Jun 19;31(10):1495-1498. doi: 10.1097/QAD.0000000000001500.
PMID: 28398959

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
Inzaule SC, Hamers RL, Kityo C, Rinke de Wit TF, Roura M.
PLoS One. 2016 Nov 29;11(11):e0167492. doi: 10.1371/journal.pone.0167492.
PMID: 27898736

Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa.
Inzaule SC, Ondoa P, Peter T, Mugyenyi PN, Stevens WS, de Wit TFR, Hamers RL.
Lancet Infect Dis. 2016 Nov;16(11):e267-e275. doi: 10.1016/S1473-3099(16)30118-9. Epub 2016 Aug 25.
PMID: 27569762